Description

Prescription Only

Sodicrom is a sterile ophthalmic solution containing Sodium Cromoglicate – a mast cell stabilizer for topical administration into the eyes.

Composition
Each ml Sodicrom eye drops contains:
Active substance: Sodium Cromoglicate BP 20 mg
Preservative: Benzalkonium Chloride 0.1 mg

Clinical Pharmacology
Sodium Cromoglicate inhibits the degranulation of sensitized mast cells which occurs after exposure to specific antigens. Sodium Cromoglicate acts by inhibiting the release of histamine and various membrane derived mediators of inflammation from mast cells. Sodium Cromoglicate has no vasoconstrictor or antihistaminic activity.

Indications and Uses
This medicine is used in different allergic conditions like vernal keratoconjunctivitis, vernal conjunctivitis, giant papillary conjunctivitis, vernal keratitis, keratoconjunctivitis, blepharitis and blepharoconjunctivitis.

Dosage and Administration
Administer 1 drop into each eye 4 times daily or as prescribed by the doctor.
Elderly: There is no evidence to suggest that dosage alteration is required for elderly patient.

Contraindications
Known hypersensitivity to Sodium Cromoglicate or any of the other ingredients.

Precautions
Patients should be advised not to wear soft contact lenses during treatment with Sodium Cromoglicate ophthalmic solution. The treatment should also be discontinued in the presence of an allergic reaction.

Side Effects

Common: Transient ocular stinging or burning upon instillation.
Rare: Watery eyes, itchy eyes, dryness around the eye, puffy eyes, eye irritation and sties. It is unclear whether they are attributable to the drug.

Pregnancy & Lactation
Pregnancy: There has been to date, no adequate and well controlled studies in pregnant women.

Lactation: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Sodium Cromoglicate is administered to a nursing woman.

Drug Interactions

Sodium Cromoglicate has been used in association with other ophthalmic solutions in the rabbit including mydriatrics, antibiotics, steroids, vasoconstrictors and astringents. No drug-drug interactions have been observed in the rabbit eyes.

Overdosage
Overdose is unlikely. In the event of accidental ingestion, symptomatic treatment is recommended.

Pharmaceutical Precautions
Store at room temperature and protect from light.
Any remaining contents should be discarded 4 weeks after opening. Do not touch dropper tip to any surface since this may contaminate the solution.

Commercial Pack

10 ml sterile ophthalmic solution in plastic dropper bottle.